FDA NDC Directory · JSON-LD · Markdown

teriparatide

NDC 47781-652 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerAlvogen, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA211939
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsTERIPARATIDE (250 ug/mL)
Marketing started20191114
Package count1

External sources

Source: openFDA. Public-domain (CC0).